This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish (read more).

Resources - Whitepapers

PERFECT POTENT API PROCESSING: Handling Hazardous Drug Actives Effectively

The journey from discovery laboratory to pharmacy shelf is long and arduous, particularly for highly potent APIs, which must be handled in compliance with complex regulatory requirements at each stage of the journey.

Pharmaceutical companies looking for a Contract Development and Manufacturing Organization (CDMO) to help them navigate should look for one with a combination of true expertise, capabilities and a robust assessment process giving all molecules a “potent passport” according to David O’Connell, Director of Pharmaceutical Development at PCI Pharma Services.

PPAP: Handling Hazardous Drug Activities Effectively

December 20, 2016


Expansion in San Diego to Maintain Industry-Leading Quality, Service and Flexibility

PCI secures third site for Clinical Trials storage, central logistics and distribution center PCI is pleased to announce the growth... View Article

Organization Updates May 2019

PCI is pleased to announce the following management updates to help drive the company’s future vision, strategy and growth. The... View Article

x